U.S. pharma big copyright scrapped two experimental weight loss supplements final yr—a after-day-to-day capsule, lotiglipron, as a result of elevated liver enzymes plus a two times-every day tablet, danuglipron, resulting from strong Unwanted effects—but CEO Albert Bourla has mention